Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

SMMT

Summit Therapeutics (SMMT)

Summit Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SMMT
DateTimeSourceHeadlineSymbolCompany
10/22/20188:15AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
10/10/20182:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in Upcoming Investor EventsNASDAQ:SMMTSummit Therapeutics Inc
10/09/20186:52AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
10/07/20189:00PMGlobeNewswire Inc.Surrender of Share OptionsNASDAQ:SMMTSummit Therapeutics Inc
10/03/20188:14AMPR Newswire (US)Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018NASDAQ:SMMTSummit Therapeutics Inc
10/03/20182:00AMGlobeNewswire Inc.Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018NASDAQ:SMMTSummit Therapeutics Inc
09/26/20182:00AMGlobeNewswire Inc.Summit to Highlight Potential of Precision Antibiotic Ridinilazole to Treat C. difficile Infection and Reduce Recurrent Disea...NASDAQ:SMMTSummit Therapeutics Inc
09/20/20188:36AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/20/20182:00AMGlobeNewswire Inc.Summit Reports Financial Results for the Second Quarter Ended 31 July 2018 and Operational ProgressNASDAQ:SMMTSummit Therapeutics Inc
09/14/20182:00AMGlobeNewswire Inc.Summit Therapeutics to Report Financial Results for the Second Quarter and Half Year Ended 31 July 2018 on 20 September 2018NASDAQ:SMMTSummit Therapeutics Inc
09/14/20182:00AMGlobeNewswire Inc.Summit Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:SMMTSummit Therapeutics Inc
09/06/20182:00AMGlobeNewswire Inc.Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen TargetsNASDAQ:SMMTSummit Therapeutics Inc
09/05/20187:07AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
09/05/20182:00AMGlobeNewswire Inc.Summit Nominates New Mechanism Antibiotic SMT-571 as its Lead Clinical Candidate for the Treatment of GonorrhoeaNASDAQ:SMMTSummit Therapeutics Inc
09/03/20184:12AMGlobeNewswire Inc.Total voting rightsNASDAQ:SMMTSummit Therapeutics Inc
08/29/20186:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment ConferenceNASDAQ:SMMTSummit Therapeutics Inc
08/16/20187:59AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
08/16/20186:00AMGlobeNewswire Inc.Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. diff...NASDAQ:SMMTSummit Therapeutics Inc
08/06/20186:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the Canaccord Genuity Growth ConferenceNASDAQ:SMMTSummit Therapeutics Inc
08/02/20181:00PMGlobeNewswire Inc.Phase 2 Clinical Data Published Showing Summit’s Ridinilazole Preserved the Gut Microbiome of Patients with C. difficile In...NASDAQ:SMMTSummit Therapeutics Inc
07/30/20189:47AMPR Newswire (US)Summit Therapeutics Joins Antimicrobials Working GroupNASDAQ:SMMTSummit Therapeutics Inc
07/17/20186:32AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
07/16/20183:19PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
07/10/20187:02AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/28/20184:06PMDow Jones NewsADRs End HigherNASDAQ:SMMTSummit Therapeutics Inc
06/27/20186:32AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
06/27/20186:00AMGlobeNewswire Inc.Summit Announces PhaseOut DMD Did Not Meet Primary EndpointNASDAQ:SMMTSummit Therapeutics Inc
06/15/20186:00AMGlobeNewswire Inc.Summit Therapeutics to Present at the JMP Securities Life Sciences ConferenceNASDAQ:SMMTSummit Therapeutics Inc
06/11/20186:00AMGlobeNewswire Inc.Summit Unveils Second Novel Target for Gonorrhoea at ASM Microbe 2018NASDAQ:SMMTSummit Therapeutics Inc
06/07/20183:12PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:SMMTSummit Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SMMT